The role of antibody delivery formation in cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of antibody delivery formation in cancer therapy

Published:2020-02-18 Issue:6 Volume:28 Page:574-584
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Qi Tongtong¹,Shi Yanbin²,Huang Yi¹,Fu Xianglei¹,Qiu Shengnan¹,Sun Qifeng³,Lin Guimei¹

Affiliation:

1. School of Pharmaceutical Science, Shandong University, Jinan, PR China;

2. School of Mechanical & Automotive Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China;

3. Department of Thoracic Surgery, Second Hospital of Shandong University, Jinan, PR China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2020.1728537

Reference149 articles.

1. Targeted cancer therapy through antibody fragments-decorated nanomedicines

2. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives

3. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy

4. Chemotherapy-induced neutropenia

5. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18

2. Engineered therapeutic proteins for sustained-release drug delivery systems;Acta Biomaterialia;2023-11

3. Antibody-Functionalized Nanoparticles for Targeted Drug Delivery in Cancer Therapy;Handbook of Cancer and Immunology;2023

4. Research progress on tumor hypoxia-associative nanomedicine;Journal of Controlled Release;2022-10

5. Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy;Journal of Controlled Release;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3